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Comparison of the complete genome sequence of Bacteroides fragilis 638R, originally isolated in
the USA, was made with two previously sequenced strains isolated in the UK (NCTC 9343) and
Japan (YCH46). The presence of 10 loci containing genes associated with polysaccharide (PS)
biosynthesis, each including a putative Wzx flippase and Wzy polymerase, was confirmed in all
three strains, despite a lack of cross-reactivity between NCTC 9343 and 638R surface PS-
specific antibodies by immunolabelling and microscopy. Genomic comparisons revealed an
exceptional level of PS biosynthesis locus diversity. Of the 10 divergent PS-associated loci
apparent in each strain, none is similar between NCTC 9343 and 638R. YCH46 shares one locus
with NCTC 9343, confirmed by mAb labelling, and a second different locus with 638R, making a
total of 28 divergent PS biosynthesis loci amongst the three strains. The lack of expression of the
phase-variable large capsule (LC) in strain 638R, observed in NCTC 9343, is likely to be due to a
point mutation that generates a stop codon within a putative initiating glycosyltransferase,
necessary for the expression of the LC in NCTC 9343. Other major sequence differences were
observed to arise from different numbers and variety of inserted extra-chromosomal elements, in
particular prophages. Extensive horizontal gene transfer has occurred within these strains, despite
the presence of a significant number of divergent DNA restriction and modification systems that
act to prevent acquisition of foreign DNA. The level of amongst-strain diversity in PS biosynthesis
loci is unprecedented.
Abbreviations: ACT, Artemis Comparison Tool; GI, gastrointestinal; HMMPS, high-molecular-mass polysaccharides; LC, large capsule; MC, micro-capsule;
PS, polysaccharide; R-M systems, restriction and modification systems; SC, small capsule; SNP, single nucleotide polymorphism.
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The obligately anaerobic Gram-negative bacterium Bac-
teroides fragilis is an important member of the open-ended
culture system of the normal resident human gastro-
intestinal (GI) faecal microbiota, in which the genera
Bacteroides and related Parabacteroides predominate
both by culture (Patrick et al., 2009) and metagenomic
sequencing (Qin et al., 2010). Since the late 1800s, B.
fragilis (previously Bacillus fragilis) has also been recog-
nized as an important opportunistic pathogen. It is the
major obligately anaerobic Gram-negative bacterium iso-
lated from abscess and soft-tissue infections that arise from
contamination by the GI microbiota of normally uncolo-
nized body sites; B. fragilis is estimated to account for only
between 4 and 13% of the normal human faecal
Bacteroides microbiota by culture and is less abundant
than other members of the Bacteroidetes, as demonstrated
by metagenomic analysis, but is present in 63–80% of
Bacteroides infections. These include peritonitis subsequent
to rupture of an inflamed appendix, serious gynaecological
sepsis and brain abscesses (Patrick, 2002; Patrick &
Duerden, 2006). B. fragilis is also the most common cause
of anaerobic bacteraemia, with a potential mortality of up
to ~30% (Cheng et al., 2009). Prior to the antibiotic era,
such infections severely limited the success of GI and
gynaecological surgery due to the high rates of patient
death (Patrick & Duerden, 2006). Metronidazole is
generally the most effective antibiotic for both treatment
and prophylaxis; a recent worrying development, however,
is the report of potentially lethal multi-drug-resistant
strains (Katsandri et al., 2006; Wareham et al., 2005). In
contrast to B. fragilis, other Bacteroidetes more abundant
in the GI tract, such as Bacteroides vulgatus and
Parabacteroides distasonis (formerly Bacteroides distasonis;
Sakamoto & Benno, 2006), are rarely isolated from
infection (Patrick & Duerden, 2006). Characteristics of B.
fragilis that may play a role in its success as an
opportunistic pathogen include the release of degradative
enzymes such as fibrinogenolysin (Houston et al., 2010),
enterotoxin production, evasion of complement-mediated
killing and phagocytosis, the induction of abscess forma-
tion, and extensive within-strain variation of surface
proteins and polysaccharides (PSs) (Wexler, 2007).
Multiple invertible promoters play a key role in generating
the observed antigenic variation (Cerden ˜o-Ta ´rraga et al.,
2005; Patrick et al., 2003). The marginal electron-dense
layer, or micro-capsule (MC), of approximately 35 nm in
size, outwith the outer membrane and not visible by light
microscopy (Patrick et al., 1986; Lutton et al., 1991), is
linked to complement resistance, and at least one of these
antigenically variable PSs is associated with abscess
formation (Wexler, 2007). In addition to MC, antigenically
distinct and within strain-variable large capsules (LCs) and
small capsules (SCs) are visible by light microscopy when
cultures are grown in a glucose-defined medium (Patrick
et al., 1986). The LC is associated with resistance to
phagocytic uptake and killing (Reid & Patrick, 1984). A
putative PS chain length-determining Wzz protein homo-
logue is involved in the production of high-molecular-mass
polysaccharides (HMMPS) associated with the MC; a wzz
deletion mutant in NCTC 9343 does not produce HMMPS,
but still produces SC and LC (Patrick et al., 2009). Phase
variation of LC production is also under invertible
promoter control (Patrick et al., 2009).
We now present the complete genome sequence of a B.
fragilis plasmid-free spontaneous rifampicin-resistant
mutant, 638R (Privitera et al., 1979; also known as
TM400; Tally et al., 1982), which was generated at the
Institut Pasteur (Paris, France) from a clinical isolate
originating from Chicago, USA (Stiffler et al., 1974).
Comparison of 638R with two published B. fragilis genome
sequences, NCTC 9343 (Cerden ˜o-Ta ´rraga et al., 2005),
isolated from peritoneal infection in London (UK), and a
blood culture isolate, YCH46, isolated in Yamaguchi
(Japan; Kuwahara et al., 2004), reveals an unprecedented
diversity of PSs amongst the three strains.
METHODS
Bacterial strains and culture conditions. B. fragilis 638R (isolated
from an abdominal abscess), kindly gifted by C. J. Smith, East
Carolina University, USA, was derived from a culture supplied to him
by M. Sebald (Institut Pasteur, Paris, France) in 1983. B. fragilis
YCH46, a bacteraemia isolate from Yamaguchi Prefecture (Japan),
was kindly gifted by T. Kuwahara, University of Tokushima (Japan).
An early freeze-dried stock culture of B. fragilis National Collection of
Type Cultures (NCTC) 9343, originally isolated from an abdominal
infection at St Bartholomew’s Hospital, London, UK, in 1955, was
obtained from the NCTC, London, UK.
B. fragilis was cultured in either supplemented brain heart infusion
(BHI-S) or glucose defined medium (DM; Van Tassell & Wilkins,
1978). B. fragilis was cultured in a MACS MG-1000 anaerobic
workstation (Don Whitley) at 37 uC in an atmosphere of 80%
nitrogen, 10% carbon dioxide and 10% hydrogen. Clinical isolates
(n523) and GI tract isolates (n59) were cultured in DM broth, and
the proportion of capsulate cells was estimated by five random field
counts (Patrick & Reid, 1983). Enrichment of populations with
different sizes of capsules was carried out using discontinuous Percoll
density-gradient centrifugation, as previously described (Patrick &
Reid, 1983; Patrick et al., 2009).
B. fragilis 638R complete genome sequencing. B. fragilis 638R
was grown in DM as described above, and DNA was isolated using a
modification of the basic protocol for preparation of genomic DNA
from bacteria described by Ausubel et al. (1992). In brief, bacterial
cells were lysed in 10 mM Tris/HCl/1 mM EDTA buffer (pH 8.0)
containing SDS (0.5%), lysozyme (4 mg ml
21) and proteinase K
(0.1 mg ml
21). PS was precipitated using cetyltrimethylammonium
bromide (CTAB) and DNA was extracted with chloroform:isoamyl
alcohol and phenol:choloroform:isoamyl alcohol mixtures. DNA
was precipitated using 2-propanol, spooled out with a glass rod and
washed in ethanol. The initial genome assembly was obtained from
86560 paired-end sequences (giving ninefold coverage) derived from
two pUC18 genomic shotgun libraries (with insert sizes ranging
from 1.4 to 3.6 kb) using BigDye terminator chemistry on ABI 3700
automated sequencers. A total of 1474 paired-end sequences from a
pBACe3.6 library were used as a scaffold. All identified repeats were
bridged by read-pairs or end-sequenced PCR products. A further
14870 sequencing reads were generated during finishing. The
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previously, using Artemis to collate data and facilitate annotation
(Cerden ˜o-Ta ´rraga et al., 2005). The DNA and encoded protein
sequences of related species were compared using the Artemis
Comparison Tool (ACT; Carver et al., 2005). A percentage identity
cut-off was not set for the ACT comparisons. Whole-genome
comparisons were performed using BLAST with default parameters,
and all matches with a BLAST score .100 were collected and displayed.
Non-homologous regions showed no matches above this threshold.
Orthologous gene sets were calculated by reciprocal best match FASTA
comparisons, with subsequent manual curation. Pseudogenes had one
or more mutations that would ablate expression; each of the
inactivating mutations was subsequently checked against the original
sequencing data.
Regions associated with PS biosynthesis were numbered in the
primary annotation of the NCTC 9343 genome sequence; these
numbers have been retained along with the letters subsequently
designated for PS loci A–J (Patrick et al., 2003; Cerden ˜o-Ta ´rraga et al.,
2005) to enable cross-reference. Additional loci reported herein have
been assigned both letter and number designations.
Microscopy. Bacteria grown in DM broth to late-exponential phase
were fixed with glutaraldehyde and osmium tetroxide, and prepared
for transmission electron microscopy as previously described (Patrick
et al., 1986). Capsule smears were performed on DM-grown cultures
using Eosin–carbol fuchsin negative stain. Hybridoma cell lines
secreting mouse mAb were generated by inoculation of whole
bacterial cells, as previously described (Lutton et al., 1991) under
UK Government Home Office Personal and Project Licences and with
local ethical approval. Immunofluorescence labelling was carried out
as described by Lutton et al. (1991) with the following modifications.
Bacterial cells, grown in DM broth, were suspended at OD600 0.3
(~5610
8cells ml
21) in PBS. Bacterial suspension (10 ml) was applied
to a Teflon-coated multiwell slide (ICN Biomedicals). The slides were
then dried at 37 uC, and cells were fixed by submerging in 100%
methanol at –20 uC for 20 min. After air drying, the cells were
immunolabelled with mAb hybridoma supernatants (30 mlo fa1:1 0
dilution in PBS), incubated at 37 uC in a humidified container for
45 min, and then washed in PBS with agitation for 20 min. Secondary
antibody, 1:100 goat anti-mouse IgG–FITC (Sigma), and 4% (v/v)
Evans blue counter stain in PBS (30 ml) were added to each well.
Slides were incubated at 37 uC in a humidified container for 45 min
and washed as before, mounted in glycerol–PBS anti-bleaching
mounting fluid (Citifluor, Agar Scientific) and examined at 61000
magnification (Leitz Ortholux fluorescence microscope). Images were
captured using a Nikon DMX 1200 digital camera and Lucia G/F
software.
PCR amplification of the LC invertible promoter region. Primers
were designed which amplified the upstream region of BF2782 with
the promoter in both the ON and OFF orientations, as follows:
BF2782 ‘Promoter ON’ primers, BF2782 ON-For (59-AAAAAA-
GGATCCATTAGGTAATAAATGCGGAATAGCG-39) and BF2782
ON-Rev (59-AAAAAAGCATGCAACTCTGTGTTCTCTGTGGTG-39).
This primer set amplifies a 1.85 kb DNA sequence upstream of BF2782
which has the promoter only in the ON position with respect to the
BF2782 start codon; BF2782 ‘Promoter OFF’ primers, BF2782 OFF-
For (59-AAAAAAGGATCCCACTTAATAGAAATATTAGTC-39) and
BF2782 OFF-Rev (59-AAAAAAGCATGCAACTCTGTGTTCCTCT-
GTGGTG-39). This primer set amplifies a 1.75 kb DNA sequence
upstream of BF2782 which has the promoter only in the OFF position
with respect to the BF2782 start codon. DNA extraction and PCR were
carried out as detailed in Patrick et al. (2009), with the following
modifications. Purified genomic template DNA from each of the
enriched capsular populations and strains 638R and YCH46 was
diluted in autoclaved ultrapure water to give final concentrations of
100 mgm l
21. PCR mixtures were prepared using Platinum Taq High
Fidelity DNA polymerase (Invitrogen) according to the manufacturer’s
instructions. The reaction mixtures were incubated at 94 uC for 3 min
followed by 35 cycles of PCR amplification at 94 uC for 30 s, annealing
at 60 uC for 15 s, extension at 68 uC for 1 min, and a final extension
step at 68 uC for 10 min. PCR products were detected as described in
Patrick et al. (2009).
Transformation of strain 638R with pVA2198-BF2782.
Transformation was performed using pVA2198-BF2782, with the
bacteria maintained in an anaerobic atmosphere throughout, as
described in Patrick et al. (2009), with the following modifications.
Under anaerobic conditions, B. fragilis, Ocr protein (8–16 mg), and
plasmid (3.25 mg of pVA2198-BF2782 per electroporation) were
added to the electroporation cuvette and mixed. As positive controls,
B. fragilis 638R and NCTC 9343 were also electroporated with
pVA2198 (500 ng plasmid and 8–16 mg Ocr protein). Transformed
cells were initially plated onto BHI-S agar plates containing 10 mg
erythromycin ml
21 with or without 20 mg rifampicin ml
21.
Transformants were subcultured by patch plating individual colonies
onto glucose DM agar plates containing 10 mg erythromycin ml
21
with or without 20 mg rifampicin ml
21 prior to performing capsule
smears and microscopy.
RESULTS AND DISCUSSION
Within-strain antigenically variable MC
comparisons
Within-strain antigenic variation of MC expression, driven
by invertible promoters, is evident in B. fragilis NCTC 9343
and a range of other clinical isolates by reaction with a suite
of mAbs. The rate of DNA inversion is sufficiently rapid to
generate variants during growth of a single colony on
glucose DM agar; thus, within a single population there are
both promoter ON and OFF bacterial cells for multiple
loci. As a result, immunofluorescence microscopy reveals,
within a single population, labelling of variable numbers of
bacterial cells with multiple different mAbs (Patrick et al.,
1999). B. fragilis 638R, however, does not react with the
suite of mAbs that react with the MC of NCTC 9343 and
also with a range of isolates from Northern Ireland (Patrick
et al., 1995); nevertheless, an electron-dense MC outwith
the outer membrane is clearly evident in 638R by electron
microscopy (Fig. 1). As previously described for NCTC
9343 (Patrick et al., 2003; Cerden ˜o-Ta ´rraga et al., 2005),
eight separate MC biosynthesis loci were also identified in
the 638R genome, each characterized by the presence of
putative O-antigen flippase genes (wzx) and polysaccharide
polymerases (wzy), indicating the production of PSs,
exported by Wzy-dependent methods (Whitfield, 2006).
Whole-genome comparison, using ACT, revealed conser-
vation of the upstream promoter regions, including the
invertible regions associated with seven of the loci (Patrick
et al., 2003). As in NCTC 9343, there is evidence of active
DNA inversion in the genome of the 638R population from
which the DNA used for genome sequencing was extracted.
Invertible promoters in both the ON and OFF positions are
present in the 638R shotgun sequence data. In addition, the
invertase finA (Patrick et al., 2003) 638R 2788, equivalent
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these loci, is conserved. The putative transcriptional
regulators up(a-h) Z and up(a-h) Y, located at the start
of seven of the PS biosynthesis loci, are also conserved,
with the exception of the C-terminal region of the 638R
upbZ. There is, however, a striking lack of DNA sequence
identity between strain 638R and strain NCTC 9343 in the
remainder of each of the loci as revealed by ACT analyses
(Fig. 2a–h, Table 1). Within the non-identical regions,
genes putatively involved in PS formation are present,
potentially representing a different set of eight PSs in strain
638R. This divergence is likely to explain the lack of cross-
reactivity of 638R with the NCTC 9343 antibodies. The PS-
associated region PSJ/10, which encodes the only Wzz
homologue, and which is involved in the generation of
HMMPS associated with the MC, but not SC or LC
formation (Patrick et al., 2009), is however conserved
amongst all three strains (results not shown).
Seven mAbs, generated using whole cells of 638R, reacted
with HMMPS from 638R as demonstrated by proteinase K
digestion, PAGE and immunoblotting (results not shown).
Immunofluorescence microscopy revealed within-popu-
lation antigenic variation in 638R, but not cross-reaction
with NCTC 9343 (Fig. 3). Further genomic comparison
with the previously sequenced Japanese strain, YCH46,
which also contains eight MC loci, revealed only two
shared loci amongst the three strains; 638R PSC/8 is shared
with YCH46, and the NCTC 9343 PSB/4 locus is shared
with YCH46. The existence of conserved loci between
NCTC 9343 and YCH46, as observed using ACT, was
confirmed experimentally by immunofluorescence micro-
scopy using a mAb that reacts with NCTC 9343 PSB/4 (Fig.
4). The zwitterionic amino sugar-containing NCTC 9343
PSA/2, which is involved in abscess formation (Coyne et al.,
2001) and which also protects animals from experimental
colitis (Mazmanian et al., 2008), is not conserved amongst
the three sequenced strains and is present in NCTC 9343
alone (Fig. 2a). Kuwahara et al. (2004) suggested that the
presence of putative aminotransferase and dehydrogenase
genes in five of the YCH46 PS loci could potentially
generate five different abscess-inducing PSs. On this basis,
four of the 638R loci that contain putative aminotrans-
ferases and dehydrogenases may produce a different set of
abscess-inducing PSs.
Within-strain phase-variable LC and SC
comparisons
As with antigenic variation of the MC, phase variation of
the LC and SC in NCTC 9343 occurs during growth of a
single population in which both phase ON and phase OFF
bacterial cells are evident. Neither 638R nor YCH46
produces an LC when cultured in a glucose DM (Van
Tassell & Wilkins, 1978); nor is it possible to enrich for an
LC population using Percoll density-gradient centrifu-
gation (Patrick & Reid, 1983; Fig. 5). Three key genes are
implicated in LC production by B. fragilis NCTC 9343:
BF2782, a putative initiating glycosyltransferase WbaP
homologue; BF2783, a putative Wza polysaccharide export/
assembly protein homologue; and BF2784, a putative
polysaccharide co-polymerase Wzc homologue.
In NCTC 9343, expression of the LC is under the control
of an invertible promoter, driven by Tsr19 (BF2780), a
tyrosine site-specific recombinase (Chatzidaki-Livanis et al.,
2008). ACT comparisons indicated that the invertible
promoter and the recombinase are conserved in 638R and
YCH46. Comparison with the published YCH46 sequence,
however, revealed that duplication of the inverted repeats
present at one end of the NCTC 9343 invertible region is
apparent at both ends of the invertible promoter region in
YCH46. How this affects inversion of this region is not
known. The invertible promoter region which mediates
this within-strain variable expression of the LC is in the
‘OFF’ orientation in all three genome sequences. This is to
Fig. 1. Electron micrographs of ultrathin
sections of B. fragilis. (a) NCTC 9343 MC-
enriched population; (b) B. fragilis 638R. Note
the presence of an electron-dense layer (black
arrow) outwith the outer membrane (white
arrow) in both strains. Bar, 200 nm.
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for the sequencing project was purified from a population
in which fewer than 1% of the cells had the LC phenotype
(Cerden ˜o-Ta ´rraga et al., 2005); therefore, it is unlikely that
inversion would be evident in the shotgun sequencing. To
determine whether active inversion occurred within the
populations, PCR amplification of purified genomic DNA
from populations of the three strains, using primer pairs
designed to amplify the BF2782-equivalent gene with its
promoter in both the ON and OFF orientations, resulted in
the detection of amplicons of the predicted size for both
orientations (Fig. 6). The promoter is therefore present in
both orientations in populations of all three strains. This
indicates the potential for phase-variable expression of the
downstream genes, the first of which is the putative WbaP
initiating glycosyltransferase. Wza proteins form major
multimeric ring-like structures in the outer membrane that
are thought to function as export channels in translocation
of HMMPS across the outer membrane, and possibly
also in assembly of the capsule on the cell surface
(Drummelsmith & Whitfield, 2000); a BF2782 deletion
mutant generated in NCTC 9343 does not exhibit the LC
phenotype (Patrick et al., 2009). The equivalent gene in
638R, BF638R 2790, contains a single nucleotide poly-
morphism (SNP) that results in a stop codon, located
within the 59 region of a putative C-terminal sugar
transferase domain, potentially resulting in the truncation
of approximately 75% of this functionally important
domain. This stop mutation may therefore abolish the
enzymic function of the glycosyltransferase, which may in
turn account for the lack of LC production by 638R.
Complementation of an NCTC 9343-BF2782 deletion
mutant with pVA2198-BF2782, containing the invertible
promoter in the ON position, restored the phase-variable
LC phenotype (Patrick et al., 2009); however, transforma-
tion of 638R with this plasmid did not result in an LC
phenotype. It is possible that the stop codon in BF638R
2790 has polar effects on transcription of the additional
downstream genes, although this will require confirmation
by analysis of transcripts.
The reason for the lack of production of the LC in YCH46
is not immediately evident from the genome sequence, as
the BF2782-equivalent gene (BF YCH46 2767) has an
identical sequence to that of NCTC 9343. There are,
however, SNPs in the downstream putative Wza BF YCH46
2768 (BF2783 equivalent), and in BF 638R 2793, equivalent
to BF2784, the putative Wzc polysaccharide co-polymerase.
These SNPs effect amino acid substitutions. Whether or
not these alter the structure and biological function of the
key capsular biosynthesis proteins remains to be deter-
mined. It may be that the lack of LC phenotype and
presence of SNPs reflect the degree of laboratory subculture
of these strains away from the selective pressures of the
human host. All recent clinical and GI tract isolates of B.
fragilis (n532) examined to date produced the LC in
proportions varying from 30 to 1% or less (results not
shown).
Populations of NCTC 9343 expressing an SC can be
obtained at the 20–40% interface layer of a Percoll
discontinuous density gradient after centrifugation
(Patrick et al., 1986). Strains 638R and YCH46 also had
an observable SC by light microscopy after negative
staining, when sampled from the 20–40% interface,
although the SC was more irregular in strain 638R (Fig.
5). Labelling of the 638R and YCH46 SC populations with
a mAb specific for the SC of NCTC 9343 (Reid et al., 1987),
however, revealed that these populations were not enriched
for the NCTC 9343 SC-associated epitope (Fig. 5). As
previously noted for NCTC 9343 (Patrick et al., 1986), the
SC population of strain 638R could be enriched by
subculture from the 20–40% Percoll interface layer into
glucose DM; however, YCH46 failed to subculture. This
may relate to the poor growth of YCH46 in glucose DM.
YCH46 is growth-limited in this medium when compared
with NCTC 9343 and 638R with respect to growth rate
(mean doubling time of approximately 4 h as opposed to
1.6 and 1.2 h, respectively) and total viable count attained
in late-exponential phase.
Comparison of two PS loci yet to be associated
with capsule type
The PS loci I/9 and K/11 are two further divergent loci that
appear to lack invertible promoters and have yet to be
associated with a particular capsular type (Fig. 7, Table 1).
In PS locus I/9 (Fig. 7a), comparison of 638R and YCH46
reveals conservation in a 12-gene region (from BF YCH46
2776 and BF 638R 2800) downstream of a predicted
promoter, which is divergent in NCTC 9343. In YCH46, an
inserted conjugative transposon disrupts the twelfth gene,
BF YCH46 2787, a putative fucosyltransferase. This may
inhibit or prevent synthesis of the PSI/9 PS or simply alter
the structure. Interestingly, the next gene immediately
downstream of BF YCH46 2787 in the locus is a putative
recombinase. If the transposon is mobile, insertion and loss
could generate variable expression of the putative PS
encoded at this locus.
In addition, two acetyltransferase-related proteins within
the PSI/9 region, otherwise conserved between YCH46 and
638R, are disrupted in 638R. A point mutation in BF638R
2810 generates a stop codon. In addition, in the BF638R
region equivalent to BFYCH46 2780, a frameshift is
generated by an additional cytosine in a run of 4 Cs. The
presence or absence of an O-acetyl group on a sugar
residue is a well-documented mediator of capsular
variation in other bacteria. For example, Escherichia coli
slipped-strand mispairing/replicative slippage can occur
during DNA replication and results from heteropolymeric
repeats in the region upstream of an O-acetyltransferase;
this generates within-strain antigenic variation of the K1 PS
(Vimr & Steenbergen, 2006). Homopolymeric repeat
regions, within and outwith coding sequences, are also
linked to variation generated by slipped-strand misparing/
replicative slippage in other bacteria (van der Woude &
Bacteroides fragilis polysaccharide diversity
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3260 Microbiology 156Baumler, 2004). A mechanism such as this could generate
antigenic variation of a PS encoded by this locus in strain
YCH46.
In NCTC 9343, the PSI/9 locus, equivalent to the 12 genes
of YCH46 and 638R, encodes an entirely different set of 18
genes associated with PS synthesis (from NCTC 9343
BF2791), indicating potential production of a different PS.
All three strains encode a putative Wzx flippase (divergent in
NCTC 9343) in this region, and there are genes containing
8–12 transmembrane segments, characteristic of Wzy
Table 1. PS biosynthesis-associated loci in B. fragilis NCTC 9343, 638R and YCH46
Locus CDSs* Phenotype association
NCTC 9343 638R YCH46
A/2 136921377 1435–1460 1430–1445 MC
B/4 189521914 1864–1883 1830–1848 MC
C/8 101121026 1076–1095 1094–1113 MC
D/5 368223697 3750–3773 3911–3923 MC
E/1 259122604 2585–2598 2566–2583 MC
F/6 155121565 1539–1563 1530–1551 MC
G/7 073320752 0778–0810 0805–0827 MC
H/3 345123464 3472–3487 3646–3665 MC
I/9 279122817 2800–3826 2776–2935 Unknown
J/10 170621710 1710–1714 1700–1704 MC
K/11 204822062 2121–2133 1995–2008 Unknown
LC assembly 278222784 2790–2793 2767–2769 LC
lfgD 429824306 4457–4465 4504–4512 Protein glycosylation
*Coding sequences.
DLocus of fragilis glycosylation.
(h)
(g)
i
ii
iii
i
(h)
Fig. 2. Four-way ACT genome comparison of within-strain variable MC-associated loci. (a) PSA/2, (b) PSB/4, (c) PSC/8, (d)
PSD/5, (e) PSE/1, (f) PSF/6, (g) PSG/7, (h) PSH/3 of B. fragilis. (i) NCTC 9343, (ii) 638R, (iii) YCH46. Red or yellow
colouration between sequences indicates sequence identity, no colour indicates divergent sequence, dark blue indicates an
inverted promoter region. Line, conserved transcriptional regulator region. Note: sequence identity was only evident between
strains NCTC 9343 and YCH46 at locus PSB/4, and strains 638R and YCH46 at locus PSC/8.
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PSs can be synthesized by an E. coli group 1 or 4 K antigen-
like mechanism (Whitfield, 2006). The 10 genes in the region
downstream are conserved amongst the three strains, and
include a number of putative exported and membrane-
associated protein genes. This region may be relevant to the
production of sugar precursors for PS synthesis. Notably,
there is a conserved B. fragilis TAnnTTTG consensus
promoter (Bayley et al., 2000) upstream of these 10 genes,
indicating possible independent transcription.
PS K/11 is a novel locus, not previously reported, but present
in all three sequenced strains. Again, there is considerable
sequence divergence in this region (Fig. 7b). It lacks any
upstream putative transcriptional regulator genes but con-
tains a putative Wzy polymerase (BF2060 in NCTC 9343) and
a putative Wzx flippase (BF2055 in NCTC 9343). This again
suggests that these PSs could be synthesized by an E. coli
group 1 or 4 K antigen-like mechanism (Whitfield, 2006).
It remains to be determined whether the PSI/9 and PSK/11
loci, which have yet to be assigned to a capsular structure,
are related to expression of the LC or SC. The locus of
fragilis glycosylation (lfg) region (Fletcher et al., 2009),
involved in protein glycosylation, is conserved amongst the
three strains (Table 1). The potential influence of other
conserved genes, putatively involved with PS export but
not situated within PS biosynthesis-associated loci, such as
BF2000 in NCTC 9343, is unknown.
PS locus comparison amongst the Bacteroidetes
Xu et al. (2007) compared capsular PS loci in single
genome sequences of B. vulgatus, Bacteroides thetaiotaomi-
Fig. 3. Immunofluorescence microscopy of B. fragilis strains. (i) NCTC 9343, (ii) 638R and (iii) YCH46 reacted with two
representative mAbs, (A) and (B), raised against B. fragilis 638R, followed by anti-mouse FITC-conjugated secondary antibody,
counter-stained with Evans blue. Exposure for fluorescein (green) image taken after shift of microscope slide (100 objective).
Note the within-strain variation in epitope expression in strain 638R and the lack of cross-reactivity with NCTC 9343 and YCH46.
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Bacteroidetes associated with the human GI tract, but are
infrequently isolated from infections. They identified nine
PS-associated loci in B. vulgatus, eight in B. thetaiotaomi-
cron and 13 in P. distasonis. In the current study, ACT
comparisons confirmed the lack of conservation with the
10 B. fragilis PS loci (results not shown). Xu et al. (2007)
reported that phage insertions disrupt four P. distasonis
capsular PS loci, including the insertion of genes between
the upstream regulatory genes (upcY and upcZ) and the
downstream PS biosynthesis gene cluster of capsular PS
locus 5 in P. distasonis. Five capsular PS biosynthesis loci of
B. vulgatus are affected by the same phage, while two
capsular loci are affected in B. thetaiotaomicron (Xu et al.,
2007). The presence of a conjugative transposon inserted
within one of the B. fragilis PS loci, YCH46 PSI/9, is
another mechanism that may mediate horizontal gene
transfer (Fig. 7). Conjugative transposons have been
reported to be associated with the duplication and
translocation of B. vulgatus PS loci (Xu et al., 2007).
DNA restriction and modification (R-M) systems
The difficulties and low efficiency of successful genetic
manipulation of Bacteroides, based on the introduction of
foreign DNA via electroporation, are well documented (e.g.
Smith, 1995). R-M systems are proposed to protect a bacterial
cell against incoming foreign DNA, particularly invading
bacteriophages, but could have similar effects on DNA
introduced for the purpose of genetic manipulation. The
human GI tract contains a significant number and diversity of
phages, as shown by metagenomic studies (Breitbart et al.,
2003). Bacteriophages may have been a significant driving
f o r c ei nr e l a t i o nt ot h ee v o l u t i o no ft h ed i v e r s i t yo fs u r f a c e
(i)
(ii)
(iii)
Fig. 4. Immunofluorescence microscopy of B. fragilis strains. (i) NCTC 9343, (ii) 638R and (iii) YCH46 reacted with mAbs
raised against NCTC 9343 followed by anti-mouse FITC-conjugated secondary antibody, counter-stained with Evans blue.
Exposure for fluorescein (green) image taken after shift of microscope slide (100 objective). QUBF6 reacts with PSE/1, and
QUBF19 reacts with PSB/4.
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9343 specifies three type I and two type III R-M systems, as
compared with the 638R genome, which specifies two type I,
one type IIS and one type III R-M systems.
Type I R-M systems consist of three subunits, HsdR, HsdM
and HsdS, the last of which dictates the DNA-binding
specificity of the methyltransferase and the endonuclease.
The NCTC 9343 genome contains a locus (BF1839–1842)
which shows phase-variable expression of an HsdS subunit
with eight different possible polypeptide combinations,
which in turn provides eight different DNA-recognition
specificities (Shufflon BB). A related hsdS shufflon (BF
638R 1146–1149) is present in the genome of 638R, but is
located in a different chromosomal location, and the
encoded polypeptides share between 27 and 49% identity
with the products of the NCTC 9343 shufflon. This
indicates that the shufflons have a common origin,
although the coding sequences have subsequently diverged.
In NCTC 9343, the shufflon contains four sets of inverted
repeats that are associated with site-specific rearrangement
(i) B. fragilis NCTC 9343                (ii) B. fragilis 638R           (iii) B. fragilis YCH46
(a)
(b)
Fig. 5. Light micrographs of eosin/carbol fuchsin negative stain (a) and immunofluorescence micrographs of bacteria reacted
with anti-NCTC 9343 SC mAb followed by anti-mouse FITC-conjugated secondary antibody counter-stained with Evans blue
(b). (i) B. fragilis NCTC 9343, (ii) 638R and (iii) YCH46 sampled from the 20–40% interface of a Percoll step density gradient
after centrifugation (100 objective). (b, i) The same microscope field illustrating antibody labelling (top) and Evans blue counter
stain (bottom); (b, ii) and (b, iii), combined fields. A small clear area can be observed surrounding the cells of B. fragilis NCTC
9343 and YCH46, indicating the expression of an SC. The capsule surrounding B. fragilis 638R appears more irregular. Note
that 638R and YCH46 SC populations are not enriched for expression of the NCTC 9343 SC-associated epitope.
Fig. 6. PCR products obtained from genomic DNA extracted from
Percoll-purified MC, SC, LC B. fragilis NCTC 9343 populations,
and mixed-capsule populations from B. fragilis 638R and YCH46,
using primer pairs designed to amplify a 1.85 kb product
comprising the complete BF2782 gene with its promoter in the
‘ON’ orientation (lanes 2–6) and a 1.75 kb product comprising the
complete BF2782 gene with its promoter in the ‘OFF’ orientation
(lanes8–12).Lanes:2 and8,NCTC9343 LCPCR;3 and9,NCTC
9343 SC PCR; 4 and 10, NCTC 9343 MC PCR; 5 and 11, 638R
PCR; 6 and 12, YCH46 PCR; 1 and 13, 1 kb Plus DNA ladder
(Invitrogen). Lane 7 is empty. Note the lack of product with the OFF
orientation primers in the NCTC 9343 LC population, lane 8.
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encoded HsdS proteins. One of these repeats (5-9CTTAT-
TGATGAACGTATCGCTACCCAAAACAAAATCAT-39)i s
conserved (32/38 bp) within the 638R shufflon, suggesting
that a common recombinase is responsible for inversion for
at least two of the TRDs. In the shufflons of both genomes,
genes encoding tyrosine integrases with 61% identity are
present immediately adjacent to the last hsdS gene,
reinforcing the notion that they mediate this subset of
inversions. Both type I R-M systems in 638R are contained
within a putative 50 kb horizontally acquired island, ICE2,
which is possibly a prophage relic. The type IIS R-M
bifunctional enzyme is encoded within a chromosomal
island in the analogous position to the island that encodes
the type I shufflon in NCTC 9343. The type III-specifying
locus in 638R (BF 638R 1130 and 1131) is the only common
R-M system amongst the three sequenced strains of B.
fragilis. Together, these observations suggest that the
common genome backbone of B. fragilis specifies a type III
R-M system and that diversification of R-M specificities
within strains is achieved by horizontal gene transfer.
The extent and variety of R-M systems in 638R will act to
prevent phage infection but will also be a barrier to
horizontal gene transfer. At least two of the conjugative
transposons that reside in the genome have evaded this
barrier by encoding homologues of the ArdA anti-
restriction protein that mimics B-form DNA and blocks
the binding site of type I R-M systems (McMahon et al.,
2009).
In addition to the classical R-M systems, the NCTC 9343
genome encodes proteins with homology to the type IV
restriction endonuclease McrBC, which cleaves specific
DNA sequences modified with 5-methylcytosine. These
genes are not present in the genome of 638R, and their
absence, despite the potential expression of nine different
type I R-M specificities, might contribute to the successful
transformation of the strain using DNA derived from E.
coli K-12 that is usually modified by the Dcm methyl-
transferase.
The R-M systems encoded within B. fragilis are undoubt-
edly responsible for the low efficiency of successful genetic
manipulation based on the introduction of foreign DNA
via electroporation, in particular in relation to NCTC 9343
(e.g. Smith, 1995). This is also in keeping with the observed
improvement of electroporation efficiency when the
bacteriophage T7 Ocr (overcomes classical restriction)
Fig. 7. Four-way ACT genome comparison of PS-associated loci. (a) PSI/9: black arrows, inserted conjugative transposon-
associated regions in YCH46; (b) PSK/11 of B. fragilis. (i) NCTC 9343, (ii) 638R, (iii) YCH46. Red or yellow coloration
between sequences indicates sequence identity, no colour indicates divergent sequence.
Bacteroides fragilis polysaccharide diversity
http://mic.sgmjournals.org 3265protein, a DNA mimic, is included in the electroporation
mix (Patrick et al., 2009). Ocr protein reduces the activity
of type I R-M systems in a range of bacteria and archaea
(Dryden, 2006).
General genomic comparisons
The general characteristics of the three genomes are
broadly similar (Table 2). Regions of low or no sequence
identity amongst the three individual genomes account for
approximately 11% of the genome sequences. These non-
identical regions include the PS regions as discussed above,
and differences in inserted extra-chromosomal elements
(ICEs) such as conjugative transposons and prophages.
Differences in numbers of ICEs also largely account for
differences in chromosomal size between the strains.
Invertible regions. A major unusual feature of the B.
fragilis genome, first identified in NCTC 9343, is the
diversity and extent of invertible DNA elements within the
genome. These include 16 fragilis invertible (fin) promoter
regions, in addition to those controlling PS loci and three
complex invertible DNA shufflons (Cerden ˜o-Ta ´rraga et al.,
2005). Conserved fin regions, not associated with PS loci,
are evident throughout all three genomes. Invertible
regions R and S, which involve putative outer-membrane
proteins, are present in all three strains. An overlap of
inverted repeat regions in R and S is evident in the
comparison of the three genomes, suggesting that these two
regions together may generate multiple rearrangements,
thus forming a further complex gene shufflon (Fig. 8). The
invertible region Q, which causes alteration of the
orientation of two hypothetical proteins with or against
the direction of transcription of the surrounding genes, is,
however, missing from 638R, as is the complete putative
phage-associated region. The previously described complex
invertible region shufflons CC and EE in NCTC 9343
(Cerden ˜o-Ta ´rraga et al., 2005) are present in both 638R
and YCH46, although only in NCTC 9343 does the
shufflon EE contain an inserted conjugative transposon.
The function of these many potentially variable surface
proteins is unknown, but it would be interesting to
determine whether they are linked to bacteriophage
adsorption.
Origin of 638R rifampicin resistance. The spontaneous
rifampicin-resistant mutant strain 638R (Privitera et al.,
1979) was generated at the Institut Pasteur from a clinical
isolate originating from Chicago (Stiffler et al., 1974).
Rifampicin binds within the DNA/RNA channel of the b
subunit in RNA polymerase and blocks the exit path for the
nascent transcript. There is a single putative rpoC RNA
polymerase b subunit homologue in all three B. fragilis
genomes. Comparison of the nucleotide sequence reveals
12 single base pair changes; however, only one results in an
altered amino acid. A transition at base pair 1475 results in
the loss of a conserved serine, which is replaced with a
phenylalanine. Serine 492 in Bf-RpoC corresponds to
serine 411 in the Thermus aquaticus (Taq) RNA
polymerase, which forms a hydrogen bond with oxygen 2
in the naphthol ring of rifampicin (Campbell et al., 2001).
Mutations that change serine 411 to phenylalanine in Taq
RNA polymerase make the enzyme insensitive to
rifampicin; this is also true for the corresponding S531F
change in the b subunit of E. coli RNA polymerase
(Campbell et al., 2005).
Conclusion
Each B. fragilis strain examined has 10 separate divergent
PS regions, each potentially capable of generating an
extracellular PS, of which only two are conserved between
two of the strains. There is, therefore, the potential for the
expression of 28 different PSs amongst these three strains.
This represents an unprecedented diversity of PSs within
such a limited number of strains. For example, in
Streptococcus pneumoniae, although there are 90 different
PS loci, each confers a single serotype on a single strain
(Bentley et al., 2006).
Surface component variation may enhance survival when
B. fragilis escapes into other body sites and generates
opportunistic infection, but this does not fully explain why
B. fragilis is more commonly associated with opportunistic
infections, including bacteraemia, when compared with
other members of the Bacteroidetes. Undoubtedly a
number of factors in combination will contribute to
virulence. For example, a fibrinogen-binding protein
identified in NCTC 9343 (Houston et al., 2010) is
conserved amongst the three sequenced B. fragilis strains
NCTC 9343, 638R and YCH46, which were isolated from
abscess and bacteraemia patients, but is not conserved in B.
vulgatus and shares only 33% identity to a putative cell
surface antigen of B. thetaiotaomicron (BT_1896), both of
which are rarely isolated from clinical infections.
The multiple and diverse PS biosynthesis loci in B. fragilis
and other members of the Bacteroidetes indicate a strong
selective pressure in favour of PS variation within the
human GI tract. It is likely that these have arisen from a
Table 2. General genomic comparison of B. fragilis NCTC
9343, 638R and YCH46
Parameter Strain
NCTC 9343* 638R YCH46D
Genome size (bp) 5205140 5373121 5277274
CDSsd 4241 4308 4578
Plasmid pBF9343
(36.6 kb)
0 pBFY46
(33.7 kb)
*Cerden ˜o-Ta ´rraga et al. (2005).
DKuwahara et al. (2004).
dCoding sequences.
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with more rapid changes arising from horizontal trans-
mission amongst cells representing a pan-genome with an
extensive pool of different PS loci. Interestingly, horizontal
gene transfer has occurred despite the presence of a
significant barrier in the form of diverse and phase-variable
DNA R-M systems.
Given the number of phage-related regions within the B.
fragilis genome, and the presence of diverse PS loci in
Bacteroidetes infrequently associated with opportunistic
infection, such as B. vulgatus and P. distasonis, it may be
that a major driver of amongst-strain PS locus diversity,
within-strain surface protein and PS diversity generated by
DNA inversion (Cerden ˜o-Ta ´rraga et al., 2005), and
extensive DNA restriction and modification, is the
prevention of bacteriophage adsorption and infection
within the GI tract.
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